Jump to content

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte (Q47767216)

From Wikidata

scientific article published on April 1, 1998

Language	Label	Description	Also known as
default for all languages	No label defined
English	Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte	scientific article published on April 1, 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

0 references

protein biosynthesis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

antidiuretic hormone receptor antagonists

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

author name string

A. Tahara

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

Y. Tomura

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

K. Wada

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

T. Kusayama

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

J. Tsukada

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

N. Ishii

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

T. Yatsu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

W. Uchida

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

A. Tanaka

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9683922

2 January 2025

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

April 1998

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9683922

2 January 2025

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9683922

2 January 2025

Cardiovascular Research

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

38

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

198-205

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Specific receptor for endothelin in cultured rat cardiocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Vasopressin increases cytosolic free [Ca2+] in the neonatal rat cardiomyocyte. Evidence for V1 subtype receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Inhibition of vasopressin action in vascular smooth muscle by the V1 antagonist OPC-21268

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Effects of a nonpeptide vasopressin antagonist (OPC-21268) on cytosolic Ca2+ concentration in vascular and cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Direct identification of the rat hepatocyte arginine8 vasopressin receptor with a radiolabelled V1-selective antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Signal transduction of V1-vascular vasopressin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Mitogen-activated protein kinases: versatile transducers for cell signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Vasopressin stimulation of mouse 3T3 cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Arginine vasopressin gene expression in chronic cardiac failure in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Hemodynamic effects of infused arginine vasopressin in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2897%2900324-6

7 January 2021

[Ca2+]i and protein kinase C in vasopressin-induced prostacyclin and ANP release in rat cardiomyocytes

7

1 reference

10.1016/S0008-6363(97)00324-6

https://api.crossref.org/works/10.1016/S0008-6363(97)00324-6

2 January 2025

Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors

8

1 reference

10.1016/S0008-6363(97)00324-6

https://api.crossref.org/works/10.1016/S0008-6363(97)00324-6

2 January 2025

Pharmacology and clinical perspectives of vasopressin antagonists

9

1 reference

10.1016/S0008-6363(97)00324-6

https://api.crossref.org/works/10.1016/S0008-6363(97)00324-6

2 January 2025

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

19

1 reference

10.1016/S0008-6363(97)00324-6

https://api.crossref.org/works/10.1016/S0008-6363(97)00324-6

2 January 2025

Functional characterization of vasopressin V1 and V2 receptors in the rabbit renal cortical collecting duct

22

1 reference

10.1016/S0008-6363(97)00324-6

https://api.crossref.org/works/10.1016/S0008-6363(97)00324-6

2 January 2025

Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo

23

1 reference

10.1016/S0008-6363(97)00324-6

https://api.crossref.org/works/10.1016/S0008-6363(97)00324-6

2 January 2025

Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells

30

1 reference

10.1016/S0008-6363(97)00324-6

https://api.crossref.org/works/10.1016/S0008-6363(97)00324-6

2 January 2025

Vasopressin modulates liver regeneration in the Brattleboro rat

39

1 reference

10.1016/S0008-6363(97)00324-6

https://api.crossref.org/works/10.1016/S0008-6363(97)00324-6

2 January 2025

Identifiers

10.1016/S0008-6363(97)00324-6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9683922

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47767216&oldid=2293932590"